Cargando…

Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension

Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening cardiopulmonary disease lacking specific diagnostic markers and targeted therapy, and its mechanism of development remains to be elucidated. The present study aimed to explore novel diagnostic biomarkers and therapeutic targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wenchao, Tang, Yiyang, Zhang, Mengqiu, Liang, Benhui, Wang, Meijuan, Zha, Lihuang, Yu, Zaixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133447/
https://www.ncbi.nlm.nih.gov/pubmed/35646965
http://dx.doi.org/10.3389/fmed.2022.894584
_version_ 1784713570304393216
author Lin, Wenchao
Tang, Yiyang
Zhang, Mengqiu
Liang, Benhui
Wang, Meijuan
Zha, Lihuang
Yu, Zaixin
author_facet Lin, Wenchao
Tang, Yiyang
Zhang, Mengqiu
Liang, Benhui
Wang, Meijuan
Zha, Lihuang
Yu, Zaixin
author_sort Lin, Wenchao
collection PubMed
description Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening cardiopulmonary disease lacking specific diagnostic markers and targeted therapy, and its mechanism of development remains to be elucidated. The present study aimed to explore novel diagnostic biomarkers and therapeutic targets in IPAH by integrated bioinformatics analysis. Four eligible datasets (GSE117261, GSE15197, GSE53408, GSE48149) was firstly downloaded from GEO database and subsequently integrated by Robust rank aggregation (RRA) method to screen robust differentially expressed genes (DEGs). Then functional annotation of robust DEGs was performed by GO and KEGG enrichment analysis. The protein-protein interaction (PPI) network was constructed followed by using MCODE and CytoHubba plug-in to identify hub genes. Finally, 10 hub genes were screened including ENO1, TALDO1, TXNRD1, SHMT2, IDH1, TKT, PGD, CXCL10, CXCL9, and CCL5. The GSE113439 dataset was used as a validation cohort to appraise these hub genes and TXNRD1 was selected for verification at the protein level. The experiment results confirmed that serum TXNRD1 concentration was lower in IPAH patients and the level of TXNRD1 had great predictive efficiency (AUC:0.795) as well as presents negative correlation with mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR). Consistently, the expression of TXNRD1 was proved to be inhibited in animal and cellular model of PAH. In addition, GSEA analysis was performed to explore the functions of TXNRD1 and the results revealed that TXNRD1 was closely correlated with mTOR signaling pathway, MYC targets, and unfolded protein response. Finally, knockdown of TXNRD1 was shown to exacerbate proliferative disorder, migration and apoptosis resistance in PASMCs. In conclusion, our study demonstrates that TXNRD1 is a promising candidate biomarker for diagnosis of IPAH and plays an important role in PAH pathogenesis, although further research is necessary.
format Online
Article
Text
id pubmed-9133447
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91334472022-05-27 Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension Lin, Wenchao Tang, Yiyang Zhang, Mengqiu Liang, Benhui Wang, Meijuan Zha, Lihuang Yu, Zaixin Front Med (Lausanne) Medicine Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening cardiopulmonary disease lacking specific diagnostic markers and targeted therapy, and its mechanism of development remains to be elucidated. The present study aimed to explore novel diagnostic biomarkers and therapeutic targets in IPAH by integrated bioinformatics analysis. Four eligible datasets (GSE117261, GSE15197, GSE53408, GSE48149) was firstly downloaded from GEO database and subsequently integrated by Robust rank aggregation (RRA) method to screen robust differentially expressed genes (DEGs). Then functional annotation of robust DEGs was performed by GO and KEGG enrichment analysis. The protein-protein interaction (PPI) network was constructed followed by using MCODE and CytoHubba plug-in to identify hub genes. Finally, 10 hub genes were screened including ENO1, TALDO1, TXNRD1, SHMT2, IDH1, TKT, PGD, CXCL10, CXCL9, and CCL5. The GSE113439 dataset was used as a validation cohort to appraise these hub genes and TXNRD1 was selected for verification at the protein level. The experiment results confirmed that serum TXNRD1 concentration was lower in IPAH patients and the level of TXNRD1 had great predictive efficiency (AUC:0.795) as well as presents negative correlation with mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR). Consistently, the expression of TXNRD1 was proved to be inhibited in animal and cellular model of PAH. In addition, GSEA analysis was performed to explore the functions of TXNRD1 and the results revealed that TXNRD1 was closely correlated with mTOR signaling pathway, MYC targets, and unfolded protein response. Finally, knockdown of TXNRD1 was shown to exacerbate proliferative disorder, migration and apoptosis resistance in PASMCs. In conclusion, our study demonstrates that TXNRD1 is a promising candidate biomarker for diagnosis of IPAH and plays an important role in PAH pathogenesis, although further research is necessary. Frontiers Media S.A. 2022-05-12 /pmc/articles/PMC9133447/ /pubmed/35646965 http://dx.doi.org/10.3389/fmed.2022.894584 Text en Copyright © 2022 Lin, Tang, Zhang, Liang, Wang, Zha and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lin, Wenchao
Tang, Yiyang
Zhang, Mengqiu
Liang, Benhui
Wang, Meijuan
Zha, Lihuang
Yu, Zaixin
Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
title Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
title_full Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
title_fullStr Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
title_full_unstemmed Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
title_short Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
title_sort integrated bioinformatic analysis reveals txnrd1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133447/
https://www.ncbi.nlm.nih.gov/pubmed/35646965
http://dx.doi.org/10.3389/fmed.2022.894584
work_keys_str_mv AT linwenchao integratedbioinformaticanalysisrevealstxnrd1asanovelbiomarkerandpotentialtherapeutictargetinidiopathicpulmonaryarterialhypertension
AT tangyiyang integratedbioinformaticanalysisrevealstxnrd1asanovelbiomarkerandpotentialtherapeutictargetinidiopathicpulmonaryarterialhypertension
AT zhangmengqiu integratedbioinformaticanalysisrevealstxnrd1asanovelbiomarkerandpotentialtherapeutictargetinidiopathicpulmonaryarterialhypertension
AT liangbenhui integratedbioinformaticanalysisrevealstxnrd1asanovelbiomarkerandpotentialtherapeutictargetinidiopathicpulmonaryarterialhypertension
AT wangmeijuan integratedbioinformaticanalysisrevealstxnrd1asanovelbiomarkerandpotentialtherapeutictargetinidiopathicpulmonaryarterialhypertension
AT zhalihuang integratedbioinformaticanalysisrevealstxnrd1asanovelbiomarkerandpotentialtherapeutictargetinidiopathicpulmonaryarterialhypertension
AT yuzaixin integratedbioinformaticanalysisrevealstxnrd1asanovelbiomarkerandpotentialtherapeutictargetinidiopathicpulmonaryarterialhypertension